Proficio Capital Partners’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-233
| Closed | -$31K | – | 1820 |
|
|
2019
Q2 | $31K | Sell |
233
-33
| -12% | -$4.39K | 0.01% | 531 |
|
|
2019
Q1 | $36K | Buy |
266
+140
| +111% | +$18.9K | 0.01% | 452 |
|
|
2018
Q4 | $12K | Sell |
126
-125
| -50% | -$11.9K | 0.01% | 701 |
|
|
2018
Q3 | $35K | Hold |
251
| – | – | 0.01% | 432 |
|
|
2018
Q2 | $31K | Buy |
251
+20
| +9% | +$2.47K | 0.01% | 475 |
|
|
2018
Q1 | $26K | Sell |
231
-51
| -18% | -$5.74K | 0.01% | 519 |
|
|
2017
Q4 | $34K | Sell |
282
-18
| -6% | -$2.17K | 0.01% | 443 |
|
|
2017
Q3 | $42K | Buy |
300
+8
| +3% | +$1.12K | 0.02% | 425 |
|
|
2017
Q2 | $40K | Buy |
292
+115
| +65% | +$15.8K | 0.02% | 438 |
|
|
2017
Q1 | $18K | Buy |
177
+14
| +9% | +$1.42K | 0.01% | 655 |
|
|
2016
Q4 | $20K | Buy |
163
+128
| +366% | +$15.7K | 0.01% | 449 |
|
|
2016
Q3 | $4K | Buy |
35
+11
| +46% | +$1.26K | ﹤0.01% | 782 |
|
|
2016
Q2 | $3K | Buy |
24
+23
| +2,300% | +$2.88K | ﹤0.01% | 802 |
|
|
2016
Q1 | $0 | Sell |
1
-45
| -98% | – | ﹤0.01% | 1204 |
|
|
2015
Q4 | $9K | Buy |
+46
| New | +$9K | 0.01% | 297 |
|